Expanding PrEP access in Kenyan maternal and child health clinics for pregnant and postpartum women
Official title: Scaling up integrated PrEP delivery in Kenyan maternal and child health clinics for pregnant and postpartum women
Funded at University of Washington · NIH-11224068 · Data updated 2026-11-12
This project will expand access to pre-exposure HIV medicine (PrEP) for pregnant and postpartum women by supporting clinics and healthcare workers in Kenya to offer it through routine maternal and child health services.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | January 1, 2024 |
| Project end | October 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $627,838 |
| NIH project number | 5R01MH135730-03 |
| Project ID | NIH-11224068 on NIH RePORTER |
Who could benefit from this research
✓Could help
Pregnant or postpartum women at risk for HIV who attend participating maternal and child health clinics in the Kenyan counties included in the project.
✕Less likely to help
People who are not pregnant or postpartum, people already living with HIV, or those who do not live near participating Kenyan clinics are unlikely to benefit directly from participation.
What this research studies
If I'm pregnant or recently had a baby in Kenya, this project will help my local maternal and child health clinic offer PrEP and make it easier for me to start and keep using it. The team will work with healthcare workers and local stakeholders to create a Community of Practice for training, sharing experience, and improving how PrEP is delivered. They will roll out a package of scale-up strategies across many clinics in different counties and track uptake, continuation, and service delivery outcomes. The work happens in real clinics during regular visits so it focuses on practical ways to reach more women during pregnancy and after childbirth.
Why it matters
Potential benefit: If successful, more pregnant and postpartum women could get and stay on PrEP, lowering their chance of acquiring HIV.
How similar studies have gone: Previous implementation projects in western Kenya showed that integrating PrEP into maternal and child health clinics is feasible and acceptable, though large-scale roll-out strategies remain relatively new.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Wagner, Anjuli Dawn — University of Washington
- Study coordinator: Wagner, Anjuli Dawn
Related research
Other NIH-funded projects on the same topics.
-
Healthy Families-PrEP: helping women in Uganda start and stay on PrEP during periconception, pregnancy, and postpartum
A program in Uganda helps periconception, pregnant, and postpartum women use PrEP safely to prevent HIV, with support sessions and monitoring.
-
Healthy Families-PrEP: helping pregnant and new mothers in Uganda stay HIV-free
A family-focused program in Uganda tests an approach to help women who are planning pregnancy or are pregnant or postpartum use PrEP to prevent HIV infection.
-
Injectable HIV PrEP in maternity clinics to protect pregnant and postpartum women
A doctor-scientist team is testing a twice-yearly injectable HIV prevention medicine for pregnant and postpartum women in high-risk areas to help keep them and their babies HIV-free.
-
Stepped care to improve PrEP use for pregnant and breastfeeding women in South Africa
This project offers a stepped approach to help pregnant and breastfeeding women in South Africa start and keep using HIV prevention medicine (PrEP).
-
PrEP in Pregnancy and Postpartum Data Hub
A patient-friendly data-sharing project that brings together information from many pregnancy and postpartum PrEP studies to better understand HIV prevention for mothers and their babies.
-
Improving HIV prevention for pregnant and postpartum women in South Africa
This study is looking to improve how well pregnant and new moms at high risk for HIV in South Africa can stick to taking their preventive medication, PrEP, by offering better support and easier access, so they can stay healthy and protect their babies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.